 The study found that a combination of ablative fractional CO2 laser, topical compound beta-methasone solution, and NBUVB improved the response rate of refractory acrylvitiligo in 51.6% of subjects compared to 35.8% in the control group, with no severe adverse events reported during the trial. This article was authored by Lin Yu, Yang Wu, Zhenzhen Zhang, and others.